Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Journal of Investigative Dermatology - United Kingdom
doi 10.1038/jid.2014.512

Related search